Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Cancer Screening Trial Using A Group of Radiological Approaches Including MRI and Ultrasound

NCT03702439 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03702439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03702439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Cancer Screening Trial Using A Group of Radiological Approaches Including MRI and Ultrasound
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
October 10, 2018
Completion date
August 22, 2019
Enrollment
411 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate neoplasm